Hester Biosciences is planning to expand its capacity in preparation for the production of increased quantities of the Goat Pox vaccine. Further, to assure the continued production and delivery of all other vaccinations against poultry, sheep, goat, and cattle. This capacity increase is scheduled to be finished in January 2023.

Furthermore, ICAR-IVRI has collaborated to develop a vaccine for Lumpy Skin Disease. Hester will acquire the technology and produce and sell the Lumpy Skin Disease Vaccine as soon as the technology becomes available.